Top Markets
Coin of the day
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Rang în acțiuni #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Preț acțiune
$0.30840035
Capitalizare de piață
$94.37M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-34.60%
Țară
FR
Tranzacționează Sensorion SA (ALSEN)

Categorie

Istoricul spliturilor pentru Sensorion SA (ALSEN)
Acțiunea Sensorion SA (simbol: ALSEN) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Jul 13, 2026.
O acțiune ALSEN cumpărată înainte de Jul 13, 2026 este echivalentă astăzi cu 0 acțiuni ALSEN.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
5 x199
DK
1 x2
US
0 -
US
0 -
BE
0 -
NL